NYSE · Financial Statements
Globus Medical, Inc. (GMED) Financial Statements
$76.71
NYSE: GMED
Market Cap $10.30B
Overview Financials Dividend Globus Medical, Inc. most recently reported annual revenue of $2.9B, net profit of $538.0M. Revenue grew at an average annual rate of 30.1% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $958.0M $1.0B $1.6B $2.5B $2.9B Operating Profit $172.0M $228.0M $133.0M $166.0M $480.0M Net Profit $149.0M $190.0M $123.0M $103.0M $538.0M EPS $1.44 $1.85 $1.07 $0.75 $3.92 Op Margin 17.9% 22.3% 8.5% 6.6% 16.3%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $2.0B $2.1B $5.1B $5.3B $5.3B Total Liabilities $216.0M $230.0M $1.1B $1.1B $730.0M Cash $193.0M $150.0M $467.0M $784.0M $526.0M Borrowings $0 $6.0M $520.0M $537.0M $119.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $276.0M $178.0M $243.0M $521.0M $753.0M Investing Cash Flow $-433.0M $-184.0M $225.0M $-291.0M $-520.0M Financing Cash Flow $54.0M $-110.0M $-232.0M $-28.0M $-679.0M Net Cash Flow $-46.0M $-43.0M $317.0M $317.0M $-258.0M Free Cash Flow $219.0M $104.0M $165.0M $405.0M $589.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.37 EV / EBITDA 11.18 FCF Yield 7.36% Quick Ratio 2.93 Interest Coverage — Return 1Y 25.23% Return 3Y 40.80% Return 5Y -2.33%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .